For more information please contact the Press Office:
Tel: +49 6221 387-8443
Tel: +49 6221 387-8726
Heidelberg, 7 November 2019 Integrating imaging research across Europe The European Commission has officially established Euro-BioImaging – which provides life scientists with open access to a broad range of technologies and resources in biological and biomedical imaging – as a European Research Infrastructure Consortium (ERIC). Since Euro-BioImaging was initiated at EMBL in 2007, this adds yet another remarkable achievement to EMBL’s mission of integrating European life sciences.
Heidelberg, 4 November 2019 EMBL spins the Sleeping Beauty transposase EMBL scientists have developed a new variant of the Sleeping Beauty transposase. It has dramatically improved biochemical features, including enhanced stability and intrinsic cell penetrating properties. This transposase can be used for genome engineering of stem cells and therapeutic T cells. As such it is extremely valuable for use in regenerative medicine and cancer immunotherapy. The underlying genome engineering procedures will in the future also reduce costs and improve the safety of genome modifications.
Barcelona, 20 September 2019 Discover the research schooner Tara and her new microplastics mission in the Barcelona harbour on 4 October The European Molecular Biology Laboratory (EMBL) in Barcelona and the Tara Ocean Foundation invite you to a press conference on the rising threat of microplastics in European rivers and the ocean
Grenoble, 16 September 2019 Discover the research schooner Tara and her new microplastics mission in the Old Port of Marseille on 27 September The Tara Ocean Foundation and the European Molecular Biology Laboratory (EMBL) in Grenoble invite journalists to a press conference in Marseille on the rising threat of microplastics in European rivers and the ocean. The press conference also provides the opportunity to discover the interdisciplinary research of EMBL, major partner of the Tara expeditions and the place where the idea for Tara Oceans (2009–2013) was born.
Hinxton, 13 September 2019 B cells linked to immunotherapy Researchers at EMBL’s European Bioinformatics Institute and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.
Rome, 4 September 2019 Discover the research schooner Tara and her new microplastics mission in the Rome harbour on 13 September The Tara Ocean Foundation and the European Molecular Biology Laboratory (EMBL) in Rome invite journalists to a press conference on the rising threat of microplastics in European rivers and the ocean. The press conference also provides the opportunity to discover the interdisciplinary research of EMBL, major partner of the Tara expeditions and the place where the idea for Tara Oceans (2009–2013) was born.
Grenoble, 20 August 2019 ‘Kissing loops’ in RNA molecule essential for its role in tumour suppression A team of researchers in the Marcia group at EMBL Grenoble, France, have discovered that the tumour suppressor MEG3 adopts a complex three-dimensional structure to fulfil its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture. The results of this study, published in Molecular Cell, might help to advance diagnosis and treatment of certain types of cancer.
Hinxton, 14 August 2019 Pinpointing the molecular mechanisms of ageing Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI), the Babraham Institute and collaborators have used the epigenetic clock to explore the molecular mechanisms that may drive ageing in humans. They found one gene, called NSD1, that seems to be closely linked to the process. This type of research could advance our understanding of ageing.
Grenoble, 22 July 2019 Toxin responsible for Legionella growth identified A team of scientists led by EMBL group leader Sagar Bhogaraju and Ivan Dikic of Goethe University, Frankfurt, discovered that the toxin SidJ in Legionella bacteria enforces a unique modification on human proteins and helps legionella grow inside human cells. SidJ hijacks human protein Calmodulin to its own advantage in one of the classic examples of pathogenic bacteria exploiting the human molecular machinery and turning it against us. This makes SidJ an ideal target to curb Legionella infection. The results have been published in Nature.
Heidelberg, 16 July 2019 Dieter Schwarz Foundation supports Life Science Alliance Today, representatives from the Dieter Schwarz Foundation announced funding to the European Molecular Biology Laboratory (EMBL) to support its collaborative effort with the Stanford University School of Medicine, called the EMBL | Stanford Life Science Alliance.
Policy regarding use
Press and Picture Releases
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.